Table 1.
Clinicopathologic characteristics (N = 29)
| patients, n (%) | Subtype I | Subtype II | p value | |
|---|---|---|---|---|
| Age (year) | ||||
| Mean | 56 | 54 | 60 | |
| Range | 35–73 | 35–73 | 41–71 | |
| Race | ||||
| White | 20 | 14 | 6 | |
| Black or African American | 4 | 2 | 2 | |
| Asian | 1 | 1 | 0 | |
| Unknown | 4 | 3 | 1 | |
| Tumor weight | 0.4 | |||
| Mean | 341.83 | 303.8 | 426.33 | |
| Range | 55–1100 | 58–1100 | 55–1077 | |
| Treatment best response | 0.04 | |||
| Complete Response | 8(27%) | 6 | 2 | |
| Partial Response | 2(7%) | 0 | 2 | |
| Clinical Progressive Disease | 4(14%) | 4 | 0 | |
| Unknown | 15(52%) | 10 | 5 | |
| Metastatic disease confirmed | 0.18 | |||
| YES | 10 (34%) | 5 | 5 | |
| NO | 11 (38%) | 9 | 2 | |
| Unknown | 8 (28%) | 6 | 2 | |
| Contiguous organ invaded | 0.24 | |||
| YES | 4(14%) | 2 | 2 | |
| NO | 8 (28%) | 7 | 1 | |
| Unknown | 17 (58%) | 11 | 6 | |
| Necrosis percent | 0.52 | |||
| Mean | 20.33 | 23.5 | 14 | |
| Range | 0–50 | 1–50 | 0–33 | |
* p < 0.05